Cosmetic ingredients maker United-Guardian's Q1 revenue and profit rise
United-Guardian, Inc. UG | 0.00 |
Overview
U.S. specialty ingredients maker's Q1 revenue and net income rose yr/yr
Growth driven by higher pharmaceutical and cosmetic ingredient sales
Q1 income supplemented by settlement income from contract manufacturer shutdown in late 2023
Outlook
Company expects sales to continue increasing in 2026
Result Drivers
PHARMACEUTICAL SALES - Q1 pharmaceutical sales rose 24%, driven by increased demand for Renacidin
COSMETIC INGREDIENTS - Sales of cosmetic ingredients increased 21%, mainly due to a 45% rise in purchases by distributor ASI as it resumed regular buying after working off excess inventory
SETTLEMENT INCOME - Q1 net income was supplemented by settlement income related to a contract manufacturer shutdown in late 2023, which resulted in lost Renacidin sales
Company press release: ID:nGNX8k5TrH
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Revenue |
|
$2.87 mln |
|
Q1 EPS |
|
$0.18 |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.